Net profit of Aarti Drugs declined 11.57% to Rs 35.01 crore in the quarter ended September 2024 as against Rs 39.59 crore during the previous quarter ended September 2023. Sales declined 6.74% to Rs 598.33 crore in the quarter ended September 2024 as against Rs 641.54 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales598.33641.54 -7 OPM %11.2111.92 - PBDT59.6068.88 -13 PBT45.8856.27 -18 NP35.0139.59 -12 Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 24 October 2024.Powered by Capital Market - Live News

Aarti Drugs announced that the bidding process of buyback offer will remain open on Monday, 16 September 2024 (SEBI working day) and close tender offer on Thursday, 19 September 2024 (except Wednesday, 18 September 2024, being holiday). Powered by Capital Market - Live News

Aarti Drugs announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live News

The Board of Aarti Drugs at its meeting held on 26 August 2024 has approved buyback of up to 6,65,000 equity shares of face value of Rs 10 each at a price of Rs 900 per share payable in cash for an aggregate amount of up to Rs 59.85 crore. Powered by Capital Market - Live News